BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2964266)

  • 1. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
    Bear HD; Susskind BM; Close KA; Barrett SK
    Cancer Res; 1988 Mar; 48(6):1422-7. PubMed ID: 2964266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL.
    Kern DE; Klarnet JP; Jensen MC; Greenberg PD
    J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cytotoxic T lymphocytes in the prevention of lupus-like disease occurring in a murine model of graft-vs-host disease.
    Via CS; Sharrow SO; Shearer GM
    J Immunol; 1987 Sep; 139(6):1840-9. PubMed ID: 2957440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.
    Bear HD
    Cancer Res; 1986 Apr; 46(4 Pt 1):1805-12. PubMed ID: 2936451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.
    Okuno K; Kikuchi Y; Tsuchida T; Hamaoka T; Igarashi T; Kato R; Takatsu K
    Jpn J Cancer Res; 1986 Jul; 77(7):711-21. PubMed ID: 3091558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
    Yamamoto H; Takata M; Fujimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of T cell differentiation factor in syngeneic lymphocyte macrophage culture for cytotoxic T lymphocyte generation.
    Ting CC; Hargrove ME; Loh NN
    J Immunol; 1986 Mar; 136(5):1726-33. PubMed ID: 2936809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [T-suppressors from tumor-bearing mice inhibit antitumor cytotoxic T-lymphocytes in monoculture].
    Lupatov AIu; Brondz BD
    Biull Eksp Biol Med; 1992 Feb; 113(2):186-7. PubMed ID: 1535235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper T cells against tumor-associated antigens (TAA): preferential induction of helper T cell activities involved in anti-TAA cytotoxic T lymphocyte and antibody responses.
    Fujiwara H; Yoshioka T; Shima J; Kosugi A; Itoh K; Hamaoka T
    J Immunol; 1986 Apr; 136(7):2715-9. PubMed ID: 3005417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
    Fukuzawa M; Via CS; Shearer GM
    J Immunol; 1988 Jul; 141(2):430-9. PubMed ID: 2968400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
    Sensi M; Orosz CG; Bach FH
    J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The activation of L3T4+ helper T cells assisting the generation of anti-tumor Lyt-2+ cytotoxic T lymphocytes: requirement of Ia-positive antigen-presenting cells for processing and presentation of tumor antigens.
    Kosugi A; Yoshioka T; Suda T; Sano H; Takahama Y; Fujiwara H; Hamaoka T
    J Leukoc Biol; 1987 Dec; 42(6):632-41. PubMed ID: 2960766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of suppressor T cells by interleukin 2.
    Ting CC; Yang SS; Hargrove ME
    J Immunol; 1984 Jul; 133(1):261-6. PubMed ID: 6233372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the minimum requirements for in vitro "cure" of tumor cells by cytotoxic T lymphocytes.
    Miki S; Ksander B; Streilein JW
    Reg Immunol; 1992; 4(6):352-62. PubMed ID: 1297406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The syngeneic T-T lymphocyte reaction (STTLR). II. Induction of primary T anti-T cell cytotoxic responses in vitro in T cell cultures stimulated with syngeneic self-reactive T cells.
    Suzuki H; Quintáns J
    J Mol Cell Immunol; 1986; 2(6):345-57. PubMed ID: 3509919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic elimination of syngeneic tumors in vivo by cytotoxic T lymphocytes generated in vitro from lymphocytes from the draining lymph nodes of tumor-bearing mice.
    Lynch DH; Miller RE
    Eur J Immunol; 1991 Jun; 21(6):1403-10. PubMed ID: 1904359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self recognition of accessory cell Ia determinants is required for the in vitro generation of hapten-specific cytotoxic T lymphocyte responses.
    Kruisbeek AM; Andrysiak PM; Singer A
    J Immunol; 1983 Oct; 131(4):1650-5. PubMed ID: 6604748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T helper cells in cytotoxic T lymphocyte development: role of L3T4(+)-dependent and -independent T helper cell pathways in virus-specific and alloreactive cytotoxic T lymphocyte responses.
    Ciavarra RP
    Cell Immunol; 1990 Feb; 125(2):363-79. PubMed ID: 2153464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro priming of tumor-reactive cytolytic T lymphocytes by combining IL-10 with B7-CD28 costimulation.
    Yang G; Hellström KE; Mizuno MT; Chen L
    J Immunol; 1995 Oct; 155(8):3897-903. PubMed ID: 7561096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.